Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 20.45
+0.35 (1.74%)
Nov 11, 2026, 2:15 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 19.18 billion as of November 10, 2026. Its market cap has increased by 26.62% in one year.
Market Cap
19.18B
Enterprise Value
18.06B
Revenue
4.98B
Global Rank
n/a
Country Rank
n/a
PE Ratio
22.74
ChartMarket Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 19.18B, an increase of 7,080.41%. That is a compound annual growth rate of 18.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 19.18B | 42.95% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 42.33B |
| Solara Active Pharma Sciences | 30.54B |
| Ind-Swift Laboratories | 30.11B |
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |
| Anlon Healthcare | 14.35B |